Home

Diseases associated with low levels of 25-D

According to the Marshall PathogenesisA description for how chronic inflammatory diseases originate and develop., chronic inflammatory disease is caused by a microbiotaThe bacterial community which causes chronic diseases - one which almost certainly includes multiple species and bacterial forms. of pathogens which interfere with proper functioning of the innate immune system. Patients suffering from inflammatory diseases have been shown to have lower than normal levels of 25-hydroxyvitamin D, and there are at least several reasons why bacterial pathogens generate this response.

A full understanding of vitamin D metabolism supports the conclusion that elevated 1,25-D and depressed 25-D are a result rather than a cause of the inflammatory process.

Lower than normal levels of 25-D have been independently associated both with all-cause mortality1) 2) and a number of chronic inflammatory diseases. The following selection of diseases (and patient groups) have been observed to display the hallmarks of this kind of dysregulated vitamin D metabolism.

Anomalies

Both lower and higher levels of 25-D are associated with increased mortality. This 2012 study analyzed blood serum from 247,574 Danish subjects and found a reverse J-curve for mortality.
  • mortality in the Danish population – A 2012 study of 247,574 subjects found that both lower and higher levels of 25-D were associated with an increased likelihood of mortality (right).69)
  • U-shaped relationship between vitamin D levels and long-term outcome. – In a 5 year follow-up of survivors of acute myocardial infarction patients with vitamin D<10ng/mL and >30ng/mL had higher mortality rate than those with intermediate values. 70)
  • risk of breast cancer – In a 2011 study of nurses who were predominantly premenopausal, circulating 25-D levels were not significantly associated with breast cancer risk.
  • risk of prostate cancer – In a 2008 nested case-control study appearing in Journal of the National Cancer Institute, Ahn et al. found that patients with the lowest levels of 25-D also had the lowest risk of prostate cancer.71)
  • risk of pancreatic cancer – Patients with the highest levels of 25-D were at greatest risk of pancreatic cancer.72)
  • some rarer cancers73) – non-Hodgkin lymphoma or cancers of the endometrium, esophagus, stomach, kidney, ovary and pancreas
  • cancer mortality – A 2010 longitudinal study found that both high and low concentrations of plasma 25(OH)D were associated with elevated risks of overall and cancer mortality, and low concentrations are associated with cardiovascular mortality.74)
  • neonatal vitamin D status and risk of schizophrenia – Danish neonates with the highest measurable levels of 25-D had a two-fold elevated risk of developing schizoprhenia. Based on this analysis, the population-attributable fraction associated with neonatal vitamin D status was 44%. The relationship was not explained by a wide range of potential confounding or interacting variables.75) This study is consistent with the explanation that higher rates of disease were caused by the immunosuppressive effects of heavy supplementation with vitamin D.
  • atrial fibrillation – According to results shared at a 2012 conference, patients with 25-D levels above 100 nanograms per 100ml, were 2.5 times more likely to have atrial fibrillation as those with more moderate levels (41-80ng/100ml).
  • atherosclerosis in African Americans – Vitamin D is widely used to treat patients with osteoporosis and/or low vitamin D levels based on a medically accepted normal range. This “normal” range is typically applied to all race groups, although it was established predominantly in whites. It is thought that as low vitamin D levels rise to the normal range with supplementation, protection from bone and heart disease (atherosclerosis) may increase, as well. Blacks generally have lower vitamin D levels than whites, partly because their darker skin pigmentation limits the amount of the vitamin produced by sunlight. “Despite” these lower vitamin D levels and dietary calcium ingestion, blacks naturally experience lower rates of osteoporosis and have far less calcium in their arteries. Studies further reveal that black patients with diabetes have half the rate of heart attack as whites, when provided equal access to health care. A 2010 study (explained here) determined the relationship between circulating vitamin D levels and arterial calcium in 340 black men and women with type 2 diabetes.76) The team concluded that higher circulating levels of 25-D in blacks were associated with higher levels of calcified atherosclerotic plaque.

===== Notes and comments =====

Sallie Q 09.16.2016 added 2016 report on U-shape curve high up on list of anomalies

===== References =====

1)
Melamed ML, Michos ED, Post W, Astor B. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med. 2008 Aug 11;168(15):1629-37. doi: 10.1001/archinte.168.15.1629.
[PMID: 18695076] [PMCID: 2677029] [DOI: 10.1001/archinte.168.15.1629]
2) , 21)
Semba RD, Houston DK, Bandinelli S, Sun K, Cherubini A, Cappola AR, Guralnik JM, Ferrucci L. Relationship of 25-hydroxyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults. Eur J Clin Nutr. 2010 Feb;64(2):203-9. doi: 10.1038/ejcn.2009.140. Epub 2009 Dec 2.
[PMID: 19953106] [PMCID: 3277831] [DOI: 10.1038/ejcn.2009.140]
3)
Laaksi I, Ruohola J, Tuohimaa P, Auvinen A, Haataja R, Pihlajamäki H, Ylikomi T. An association of serum vitamin D concentrations < 40 nmol/L with acute respiratory tract infection in young Finnish men. Am J Clin Nutr. 2007 Sep;86(3):714-7. doi: 10.1093/ajcn/86.3.714.
[PMID: 17823437] [DOI: 10.1093/ajcn/86.3.714]
4) , 22)
Fisher AH, Lomasky SJ, Fisher MJ, Oppenheim YL. Celiac disease and the endocrinologist: a diagnostic opportunity. Endocr Pract. 2008 Apr;14(3):381-8. doi: 10.4158/EP.14.3.381.
[PMID: 18463048] [DOI: 10.4158/EP.14.3.381]
5)
Chang ALS, Fu T, Amir O, Tang JY. Association of facial skin aging and vitamin D levels in middle-aged white women. Cancer Causes Control. 2010 Dec;21(12):2315-6. doi: 10.1007/s10552-010-9646-y. Epub 2010 Sep 30.
[PMID: 20882333] [PMCID: 3042365] [DOI: 10.1007/s10552-010-9646-y]
6) , 35) , 63)
Schneider B, Weber B, Frensch A, Stein J, Fritz J. Vitamin D in schizophrenia, major depression and alcoholism. J Neural Transm (Vienna). 2000;107(7):839-42. doi: 10.1007/s007020070063.
[PMID: 11005548] [DOI: 10.1007/s007020070063]
7)
Hyppönen E, Berry DJ, Wjst M, Power C. Serum 25-hydroxyvitamin D and IgE - a significant but nonlinear relationship. Allergy. 2009 Apr;64(4):613-620. doi: 10.1111/j.1398-9995.2008.01865.x.
[PMID: 19154546] [DOI: 10.1111/j.1398-9995.2008.01865.x]
8) , 10)
Brehm JM, Celedón JC, Soto-Quiros ME, Avila L, Hunninghake GM, Forno E, Laskey D, Sylvia JS, Hollis BW, Weiss ST, Litonjua AA. Serum vitamin D levels and markers of severity of childhood asthma in Costa Rica. Am J Respir Crit Care Med. 2009 May 1;179(9):765-71. doi: 10.1164/rccm.200808-1361OC. Epub 2009 Jan 29.
[PMID: 19179486] [PMCID: 2675563] [DOI: 10.1164/rccm.200808-1361OC]
9) , 61)
Evatt ML, Delong MR, Khazai N, Rosen A, Triche S, Tangpricha V. Prevalence of vitamin d insufficiency in patients with Parkinson disease and Alzheimer disease. Arch Neurol. 2008 Oct;65(10):1348-52. doi: 10.1001/archneur.65.10.1348.
[PMID: 18852350] [PMCID: 2746037] [DOI: 10.1001/archneur.65.10.1348]
11)
Khokhar JS, Brett AS, Desai A. Vitamin D deficiency masquerading as metastatic cancer: a case series. Am J Med Sci. 2009 Apr;337(4):245-7. doi: 10.1097/MAJ.0b013e3181898525.
[PMID: 19365168] [DOI: 10.1097/MAJ.0b013e3181898525]
12)
Goodwin PJ, Ennis M, Pritchard KI, Koo J, Hood N. Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer. J Clin Oncol. 2009 Aug 10;27(23):3757-63. doi: 10.1200/JCO.2008.20.0725. Epub 2009 May 18.
[PMID: 19451439] [DOI: 10.1200/JCO.2008.20.0725]
13)
Yin L, Grandi N, Raum E, Haug U, Arndt V, Brenner H. Meta-analysis: longitudinal studies of serum vitamin D and colorectal cancer risk. Aliment Pharmacol Ther. 2009 Jul 1;30(2):113-25. doi: 10.1111/j.1365-2036.2009.04022.x. Epub 2009 Apr 15.
[PMID: 19392870] [DOI: 10.1111/j.1365-2036.2009.04022.x]
14)
Lou Y, Qiao S, Talonpoika R, Syvälä H, Tuohimaa P. The role of Vitamin D3 metabolism in prostate cancer. J Steroid Biochem Mol Biol. 2004 Nov;92(4):317-25. doi: 10.1016/j.jsbmb.2004.10.007. Epub 2004 Dec 19.
[PMID: 15663995] [DOI: 10.1016/j.jsbmb.2004.10.007]
15) , 16) , 17)
Grant WB. Epidemiology of disease risks in relation to vitamin D insufficiency. Prog Biophys Mol Biol. 2006 Sep;92(1):65-79. doi: 10.1016/j.pbiomolbio.2006.02.013. Epub 2006 Feb 28.
[PMID: 16546242] [DOI: 10.1016/j.pbiomolbio.2006.02.013]
18)
Matias PJ, Ferreira C, Jorge C, Borges M, Aires I, Amaral T, Gil C, Cortez J, Ferreira A. 25-Hydroxyvitamin D3, arterial calcifications and cardiovascular risk markers in haemodialysis patients. Nephrol Dial Transplant. 2009 Feb;24(2):611-8. doi: 10.1093/ndt/gfn502. Epub 2008 Sep 4.
[PMID: 18775809] [DOI: 10.1093/ndt/gfn502]
19)
Lee JH, O'Keefe JH, Bell D, Hensrud DD, Holick MF. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor?. J Am Coll Cardiol. 2008 Dec 9;52(24):1949-56. doi: 10.1016/j.jacc.2008.08.050.
[PMID: 19055985] [DOI: 10.1016/j.jacc.2008.08.050]
20)
Kim DH, Sabour S, Sagar UN, Adams S, Whellan DJ. Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004). Am J Cardiol. 2008 Dec 1;102(11):1540-4. doi: 10.1016/j.amjcard.2008.06.067. Epub 2008 Sep 24.
[PMID: 19026311] [DOI: 10.1016/j.amjcard.2008.06.067]
23)
Arvold DS, Odean MJ, Dornfeld MP, Regal RR, Arvold JG, Karwoski GC, Mast DJ, Sanford PB, Sjoberg RJ. Correlation of symptoms with vitamin D deficiency and symptom response to cholecalciferol treatment: a randomized controlled trial. Endocr Pract. 2009 Apr;15(3):203-12. doi: 10.4158/EP.15.3.203.
[PMID: 19364687] [DOI: 10.4158/EP.15.3.203]
24)
Hillesund E, Skranes J, Trygg KU, Bøhmer T. Micronutrient status in children with cerebral palsy. Acta Paediatr. 2007 Aug;96(8):1195-8. doi: 10.1111/j.1651-2227.2007.00354.x.
[PMID: 17655620] [DOI: 10.1111/j.1651-2227.2007.00354.x]
25)
Arteh J, Narra S, Nair S. Prevalence of vitamin D deficiency in chronic liver disease. Dig Dis Sci. 2010 Sep;55(9):2624-8. doi: 10.1007/s10620-009-1069-9. Epub 2009 Dec 4.
[PMID: 19960254] [DOI: 10.1007/s10620-009-1069-9]
26)
Franco CB, Paz-Filho G, Gomes PE, Nascimento VB, Kulak CAM, Boguszewski CL, Borba VZC. Chronic obstructive pulmonary disease is associated with osteoporosis and low levels of vitamin D. Osteoporos Int. 2009 Nov;20(11):1881-7. doi: 10.1007/s00198-009-0890-5. Epub 2009 Mar 20.
[PMID: 19300892] [DOI: 10.1007/s00198-009-0890-5]
27)
Buell JS, Scott TM, Dawson-Hughes B, Dallal GE, Rosenberg IH, Folstein MF, Tucker KL. Vitamin D is associated with cognitive function in elders receiving home health services. J Gerontol A Biol Sci Med Sci. 2009 Aug;64(8):888-95. doi: 10.1093/gerona/glp032. Epub 2009 Apr 17.
[PMID: 19377013] [PMCID: 2981461] [DOI: 10.1093/gerona/glp032]
28)
Annweiler C, Allali G, Allain P, Bridenbaugh S, Schott A, Kressig RW, Beauchet O. Vitamin D and cognitive performance in adults: a systematic review. Eur J Neurol. 2009 Oct;16(10):1083-9. doi: 10.1111/j.1468-1331.2009.02755.x. Epub 2009 Jul 29.
[PMID: 19659751] [DOI: 10.1111/j.1468-1331.2009.02755.x]
29)
Zittermann A, Schleithoff SS, Koerfer R. Vitamin D insufficiency in congestive heart failure: why and what to do about it?. Heart Fail Rev. 2006 Mar;11(1):25-33. doi: 10.1007/s10741-006-9190-8.
[PMID: 16819575] [DOI: 10.1007/s10741-006-9190-8]
30)
Hagaman JT, Panos RJ, McCormack FX, Thakar CV, Wikenheiser-Brokamp KA, Shipley RT, Kinder BW. Vitamin D deficiency and reduced lung function in connective tissue-associated interstitial lung diseases. Chest. 2011 Feb;139(2):353-360. doi: 10.1378/chest.10-0968. Epub 2010 Aug 5.
[PMID: 20688927] [PMCID: 3032366] [DOI: 10.1378/chest.10-0968]
31)
Siffledeen JS, Siminoski K, Steinhart H, Greenberg G, Fedorak RN. The frequency of vitamin D deficiency in adults with Crohn's disease. Can J Gastroenterol. 2003 Aug;17(8):473-8. doi: 10.1155/2003/391308.
[PMID: 12945007] [DOI: 10.1155/2003/391308]
32)
Neville LA, Ranganathan SC. Vitamin D in infants with cystic fibrosis diagnosed by newborn screening. J Paediatr Child Health. 2009 Jan-Feb;45(1-2):36-41. doi: 10.1111/j.1440-1754.2008.01432.x.
[PMID: 19208064] [DOI: 10.1111/j.1440-1754.2008.01432.x]
33)
Pan A, Lu L, Franco OH, Yu Z, Li H, Lin X. Association between depressive symptoms and 25-hydroxyvitamin D in middle-aged and elderly Chinese. J Affect Disord. 2009 Nov;118(1-3):240-3. doi: 10.1016/j.jad.2009.02.002. Epub 2009 Feb 27.
[PMID: 19249103] [DOI: 10.1016/j.jad.2009.02.002]
34)
Nanri A, Mizoue T, Matsushita Y, Poudel-Tandukar K, Sato M, Ohta M, Mishima N. Association between serum 25-hydroxyvitamin D and depressive symptoms in Japanese: analysis by survey season. Eur J Clin Nutr. 2009 Dec;63(12):1444-7. doi: 10.1038/ejcn.2009.96. Epub 2009 Aug 19.
[PMID: 19690578] [DOI: 10.1038/ejcn.2009.96]
36)
Chowdhury TA, Boucher BJ, Hitman GA. Vitamin D and type 2 diabetes: Is there a link?. Prim Care Diabetes. 2009 May;3(2):115-6. doi: 10.1016/j.pcd.2009.03.004. Epub 2009 Apr 23.
[PMID: 19395331] [DOI: 10.1016/j.pcd.2009.03.004]
37)
Muscogiuri G, Sorice GP, Prioletta A, Policola C, Della Casa S, Pontecorvi A, Giaccari A. 25-Hydroxyvitamin D concentration correlates with insulin-sensitivity and BMI in obesity. Obesity (Silver Spring). 2010 Oct;18(10):1906-10. doi: 10.1038/oby.2010.11. Epub 2010 Feb 11.
[PMID: 20150902] [DOI: 10.1038/oby.2010.11]
38)
Svoren BM, Volkening LK, Wood JR, Laffel LMB. Significant vitamin D deficiency in youth with type 1 diabetes mellitus. J Pediatr. 2009 Jan;154(1):132-4. doi: 10.1016/j.jpeds.2008.07.015.
[PMID: 19187735] [PMCID: 2635941] [DOI: 10.1016/j.jpeds.2008.07.015]
39)
Orwoll E, Nielson CM, Marshall LM, Lambert L, Holton KF, Hoffman AR, Barrett-Connor E, Shikany JM, Dam T, Cauley JA, Osteoporotic Fractures in Men (MrOS) Study Group. Vitamin D deficiency in older men. J Clin Endocrinol Metab. 2009 Apr;94(4):1214-22. doi: 10.1210/jc.2008-1784. Epub 2009 Jan 27.
[PMID: 19174492] [PMCID: 2682464] [DOI: 10.1210/jc.2008-1784]
40)
Kuchuk NO, Pluijm SMF, van Schoor NM, Looman CWN, Smit JH, Lips P. Relationships of serum 25-hydroxyvitamin D to bone mineral density and serum parathyroid hormone and markers of bone turnover in older persons. J Clin Endocrinol Metab. 2009 Apr;94(4):1244-50. doi: 10.1210/jc.2008-1832. Epub 2009 Jan 21.
[PMID: 19158198] [DOI: 10.1210/jc.2008-1832]
41)
Phabphal K, Geater A, Leelawattana R, Sathirapunya P, Sattawatcharawanich S, Limapichat K. Prevalence and risk factors of low bone mineral density and 25-hydroxyvitamin D status in young healthy epileptic adult patients in a tropical Asian country taking antiepileptic drug. Bone. 2009 Aug;45(2):232-7. doi: 10.1016/j.bone.2009.04.235. Epub 2009 Apr 24.
[PMID: 19394456] [DOI: 10.1016/j.bone.2009.04.235]
42)
Yamashita H, Noguchi S, Takatsu K, Koike E, Murakami T, Watanabe S, Uchino S, Yamashita H, Kawamoto H. High prevalence of vitamin D deficiency in Japanese female patients with Graves' disease. Endocr J. 2001 Feb;48(1):63-9. doi: 10.1507/endocrj.48.63.
[PMID: 11403104] [DOI: 10.1507/endocrj.48.63]
43)
Mehrotra R, Kermah D, Budoff M, Salusky IB, Mao SS, Gao YL, Takasu J, Adler S, Norris K. Hypovitaminosis D in chronic kidney disease. Clin J Am Soc Nephrol. 2008 Jul;3(4):1144-51. doi: 10.2215/CJN.05781207. Epub 2008 Apr 16.
[PMID: 18417740] [PMCID: 2440286] [DOI: 10.2215/CJN.05781207]
44)
Meems LMG, van der Harst P, van Gilst WH, de Boer RA. Vitamin D biology in heart failure: molecular mechanisms and systematic review. Curr Drug Targets. 2011 Jan;12(1):29-41. doi: 10.2174/138945011793591554.
[PMID: 20795939] [DOI: 10.2174/138945011793591554]
45)
Rodríguez M, Daniels B, Gunawardene S, Robbins GK. High frequency of vitamin D deficiency in ambulatory HIV-Positive patients. AIDS Res Hum Retroviruses. 2009 Jan;25(1):9-14. doi: 10.1089/aid.2008.0183.
[PMID: 19108690] [DOI: 10.1089/aid.2008.0183]
46)
Pappa HM, Gordon CM, Saslowsky TM, Zholudev A, Horr B, Shih M, Grand RJ. Vitamin D status in children and young adults with inflammatory bowel disease. Pediatrics. 2006 Nov;118(5):1950-61. doi: 10.1542/peds.2006-0841.
[PMID: 17079566] [PMCID: 3205440] [DOI: 10.1542/peds.2006-0841]
47)
Kamen DL, Aranow C. The link between vitamin D deficiency and systemic lupus erythematosus. Curr Rheumatol Rep. 2008 Aug;10(4):273-80. doi: 10.1007/s11926-008-0044-3.
[PMID: 18662506] [DOI: 10.1007/s11926-008-0044-3]
48)
Ben-Zvi I, Aranow C, Mackay M, Stanevsky A, Kamen DL, Marinescu LM, Collins CE, Gilkeson GS, Diamond B, Hardin JA. The impact of vitamin D on dendritic cell function in patients with systemic lupus erythematosus. PLoS One. 2010 Feb 16;5(2):e9193. doi: 10.1371/journal.pone.0009193.
[PMID: 20169063] [PMCID: 2821911] [DOI: 10.1371/journal.pone.0009193]
49)
Kevin C. Maki, Martyn R. Rubin, Les G. Wong, Jamie F. McManus, Christopher D. Jensen, John W. Marshall, Andrea Lawless. Serum 25-hydroxyvitamin D is independently associated with high-density lipoprotein cholesterol and the metabolic syndrome in men and women/ 21 July 2009 (Article in Press DOI: 10.1016/j.jacl.2009.07.003).
50)
Pierrot-Deseilligny C. Clinical implications of a possible role of vitamin D in multiple sclerosis. J Neurol. 2009 Sep;256(9):1468-79. doi: 10.1007/s00415-009-5139-x. Epub 2009 Apr 28.
[PMID: 19399382] [PMCID: 2733195] [DOI: 10.1007/s00415-009-5139-x]
51)
Smolders J, Menheere P, Kessels A, Damoiseaux J, Hupperts R. Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis. Mult Scler. 2008 Nov;14(9):1220-4. doi: 10.1177/1352458508094399. Epub 2008 Jul 24.
[PMID: 18653736] [DOI: 10.1177/1352458508094399]
52)
Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med. 2008 Jun 9;168(11):1174-80. doi: 10.1001/archinte.168.11.1174.
[PMID: 18541825] [PMCID: 3719391] [DOI: 10.1001/archinte.168.11.1174]
53)
Moschonis G, Tanagra S, Koutsikas K, Nikolaidou A, Androutsos O, Manios Y. Association between serum 25-hydroxyvitamin D levels and body composition in postmenopausal women: the postmenopausal Health Study. Menopause. 2009 Jul-Aug;16(4):701-7. doi: 10.1097/gme.0b013e318199d5d5.
[PMID: 19276997] [DOI: 10.1097/gme.0b013e318199d5d5]
54)
Kremer R, Campbell PP, Reinhardt T, Gilsanz V. Vitamin D status and its relationship to body fat, final height, and peak bone mass in young women. J Clin Endocrinol Metab. 2009 Jan;94(1):67-73. doi: 10.1210/jc.2008-1575. Epub 2008 Nov 4.
[PMID: 18984659] [PMCID: 2630864] [DOI: 10.1210/jc.2008-1575]
55)
Jorde R, Sneve M, Emaus N, Figenschau Y, Grimnes G. Cross-sectional and longitudinal relation between serum 25-hydroxyvitamin D and body mass index: the Tromsø study. Eur J Nutr. 2010 Oct;49(7):401-7. doi: 10.1007/s00394-010-0098-7. Epub 2010 Mar 4.
[PMID: 20204652] [DOI: 10.1007/s00394-010-0098-7]
56)
Lane NE, Gore LR, Cummings SR, Hochberg MC, Scott JC, Williams EN, Nevitt MC. Serum vitamin D levels and incident changes of radiographic hip osteoarthritis: a longitudinal study. Study of Osteoporotic Fractures Research Group. Arthritis Rheum. 1999 May;42(5):854-60. doi: 10.1002/1529-0131(199905)42:5<854::AID-ANR3>3.0.CO;2-I.
[PMID: 10323440] [DOI: 10.1002/1529-0131(199905)42:5<854::AID-ANR3>3.0.CO;2-I]
57)
Zhao J, Zeng X, Wang J, Liu L. Association Between Calcium or Vitamin D Supplementation and Fracture Incidence in Community-Dwelling Older Adults: A Systematic Review and Meta-analysis. JAMA. 2017 Dec 26;318(24):2466-2482. doi: 10.1001/jama.2017.19344.
[PMID: 29279934] [PMCID: 5820727] [DOI: 10.1001/jama.2017.19344]
58)
Islam MZ, Shamim AA, Kemi V, Nevanlinna A, Akhtaruzzaman M, Laaksonen M, Jehan AH, Jahan K, Khan HU, Lamberg-Allardt C. Vitamin D deficiency and low bone status in adult female garment factory workers in Bangladesh. Br J Nutr. 2008 Jun;99(6):1322-9. doi: 10.1017/S0007114508894445.
[PMID: 18430266] [DOI: 10.1017/S0007114508894445]
59)
Atherton K, Berry DJ, Parsons T, Macfarlane GJ, Power C, Hyppönen E. Vitamin D and chronic widespread pain in a white middle-aged British population: evidence from a cross-sectional population survey. Ann Rheum Dis. 2009 Jun;68(6):817-22. doi: 10.1136/ard.2008.090456. Epub 2008 Aug 12.
[PMID: 18697776] [DOI: 10.1136/ard.2008.090456]
60)
Turner MK, Hooten WM, Schmidt JE, Kerkvliet JL, Townsend CO, Bruce BK. Prevalence and clinical correlates of vitamin D inadequacy among patients with chronic pain. Pain Med. 2008 Nov;9(8):979-84. doi: 10.1111/j.1526-4637.2008.00415.x. Epub 2008 Mar 11.
[PMID: 18346069] [DOI: 10.1111/j.1526-4637.2008.00415.x]
62)
Badalian SS, Rosenbaum PF. Vitamin D and pelvic floor disorders in women: results from the National Health and Nutrition Examination Survey. Obstet Gynecol. 2010 Apr;115(4):795-803. doi: 10.1097/AOG.0b013e3181d34806.
[PMID: 20308841] [DOI: 10.1097/AOG.0b013e3181d34806]
64)
Lee DM, Tajar A et al. Association between 25-hydroxyvitamin D levels and cognitive performance in middle-aged and older European men. Journal of Neurology, Neurosurgery, and Psychiatry 2009;80:722-729.
65)
Pilz S, Dobnig H, Fischer JE, Wellnitz B, Seelhorst U, Boehm BO, März W. Low vitamin d levels predict stroke in patients referred to coronary angiography. Stroke. 2008 Sep;39(9):2611-3. doi: 10.1161/STROKEAHA.107.513655. Epub 2008 Jul 17.
[PMID: 18635847] [DOI: 10.1161/STROKEAHA.107.513655]
66)
Williams B, Williams AJ, Anderson ST. Vitamin D deficiency and insufficiency in children with tuberculosis. Pediatr Infect Dis J. 2008 Oct;27(10):941-2. doi: 10.1097/INF.0b013e31817525df.
[PMID: 18776821] [DOI: 10.1097/INF.0b013e31817525df]
67)
Zold E, Szodoray P, Gaal J, Kappelmayer J, Csathy L, Gyimesi E, Zeher M, Szegedi G, Bodolay E. Vitamin D deficiency in undifferentiated connective tissue disease. Arthritis Res Ther. 2008;10(5):R123. doi: 10.1186/ar2533. Epub 2008 Oct 18.
[PMID: 18928561] [PMCID: 2592813] [DOI: 10.1186/ar2533]
68)
Bodnar LM, Krohn MA, Simhan HN. Maternal vitamin D deficiency is associated with bacterial vaginosis in the first trimester of pregnancy. J Nutr. 2009 Jun;139(6):1157-61. doi: 10.3945/jn.108.103168. Epub 2009 Apr 8.
[PMID: 19357214] [PMCID: 2682987] [DOI: 10.3945/jn.108.103168]
69)
Durup D, Jørgensen HL, Christensen J, Schwarz P, Heegaard AM, Lind B. A reverse J-shaped association of all-cause mortality with serum 25-hydroxyvitamin D in general practice: the CopD study. J Clin Endocrinol Metab. 2012 Aug;97(8):2644-52. doi: 10.1210/jc.2012-1176. Epub 2012 May 9.
[PMID: 22573406] [DOI: 10.1210/jc.2012-1176]
70)
Aleksova A, Beltrami AP, Belfiore R, Barbati G, Di Nucci M, Scapol S, De Paris V, Carriere C, Sinagra G. U-shaped relationship between vitamin D levels and long-term outcome in large cohort of survivors of acute myocardial infarction. Int J Cardiol. 2016 Nov 15;223:962-966. doi: 10.1016/j.ijcard.2016.08.322. Epub 2016 Aug 24.
[PMID: 27589046] [DOI: 10.1016/j.ijcard.2016.08.322]
71)
Ahn J, Peters U, Albanes D, Purdue MP, Abnet CC, Chatterjee N, Horst RL, Hollis BW, Huang W, Shikany JM, Hayes RB, Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Project Team. Serum vitamin D concentration and prostate cancer risk: a nested case-control study. J Natl Cancer Inst. 2008 Jun 4;100(11):796-804. doi: 10.1093/jnci/djn152. Epub 2008 May 27.
[PMID: 18505967] [PMCID: 3703748] [DOI: 10.1093/jnci/djn152]
72) , 73)
Gallicchio L, Helzlsouer KJ, Chow W, Freedman DM, Hankinson SE, Hartge P, Hartmuller V, Harvey C, Hayes RB, Horst RL, Koenig KL, Kolonel LN, Laden F, McCullough ML, Parisi D, Purdue MP, Shu X, Snyder K, Stolzenberg-Solomon RZ, Tworoger SS, Varanasi A, Virtamo J, Wilkens LR, Xiang Y, Yu K, Zeleniuch-Jacquotte A, Zheng W, Abnet CC, Albanes D, Bertrand K, Weinstein SJ. Circulating 25-hydroxyvitamin D and the risk of rarer cancers: Design and methods of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol. 2010 Jul 1;172(1):10-20. doi: 10.1093/aje/kwq116. Epub 2010 Jun 18.
[PMID: 20562188] [PMCID: 2892539] [DOI: 10.1093/aje/kwq116]
74)
Michaëlsson K, Baron JA, Snellman G, Gedeborg R, Byberg L, Sundström J, Berglund L, Arnlöv J, Hellman P, Blomhoff R, Wolk A, Garmo H, Holmberg L, Melhus H. Plasma vitamin D and mortality in older men: a community-based prospective cohort study. Am J Clin Nutr. 2010 Oct;92(4):841-8. doi: 10.3945/ajcn.2010.29749. Epub 2010 Aug 18.
[PMID: 20720256] [DOI: 10.3945/ajcn.2010.29749]
75)
McGrath JJ, Eyles DW, Pedersen CB, Anderson C, Ko P, Burne TH, Norgaard-Pedersen B, Hougaard DM, Mortensen PB. Neonatal vitamin D status and risk of schizophrenia: a population-based case-control study. Arch Gen Psychiatry. 2010 Sep;67(9):889-94. doi: 10.1001/archgenpsychiatry.2010.110.
[PMID: 20819982] [DOI: 10.1001/archgenpsychiatry.2010.110]
76)
Freedman BI, Wagenknecht LE, Hairston KG, Bowden DW, Carr JJ, Hightower RC, Gordon EJ, Xu J, Langefeld CD, Divers J. Vitamin d, adiposity, and calcified atherosclerotic plaque in african-americans. J Clin Endocrinol Metab. 2010 Mar;95(3):1076-83. doi: 10.1210/jc.2009-1797. Epub 2010 Jan 8.
[PMID: 20061416] [PMCID: 2841532] [DOI: 10.1210/jc.2009-1797]
home/pathogenesis/vitamind/low25d.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.